REPORTS

Let’s Pullulate and Expand Your Business

Contraceptives Oral Solids Market - Global Professional Analysis and Forecast to 2026

Nov 11, 2019  |  221 PAGES  |  REPORT CODE: CMM233413
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Contraceptives Oral Solids market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 6.3% during the forecast period.

This report presents the market size and development trends by detailing the Contraceptives Oral Solids market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Contraceptives Oral Solids market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Contraceptives Oral Solids industry and will help you to build a panoramic view of the industrial development.

Contraceptives Oral Solids Market, By Type:

  • Progestin only pills

  • Monophasic pills

  • Triphasic pills

  • Others

Contraceptives Oral Solids Market, By Application:

  • Hospitals

  • Pharmacies

  • Drug Stores

  • Convenience Stores

  • General Stores

  • E-commerce

  • Others

Some of the leading players are as follows:

  • Piramal Enterprises Ltd

  • Allergan,plc (Actavis)

  • Mahadev Medi World

  • Berar Trading Company

  • Merck & Co., Inc.

  • Pfizer, Inc.

  • Teva Pharmaceutical Industries Ltd

  • Mankind Pharma Ltd

  • Vea Impex

  • Bayer AG

  • Actiza Pharmaceutical Private Limited

  • Janssen Global Services

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Contraceptives Oral Solids Market: Technology Type Analysis

  • 4.1 Contraceptives Oral Solids Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Contraceptives Oral Solids Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Progestin only pills

    • 4.3.2 Monophasic pills

    • 4.3.3 Triphasic pills

    • 4.3.4 Others

5 Contraceptives Oral Solids Market: Product Analysis

  • 5.1 Contraceptives Oral Solids Product Market Share Analysis, 2018 & 2026

  • 5.2 Contraceptives Oral Solids Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Contraceptives Oral Solids Market: Application Analysis

  • 6.1 Contraceptives Oral Solids Application Market Share Analysis, 2018 & 2026

  • 6.2 Contraceptives Oral Solids Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Hospitals

    • 6.3.2 Pharmacies

    • 6.3.3 Drug Stores

    • 6.3.4 Convenience Stores

    • 6.3.5 General Stores

    • 6.3.6 E-commerce

    • 6.3.7 Others

7 Contraceptives Oral Solids Market: Regional Analysis

  • 7.1 Contraceptives Oral Solids Regional Market Share Analysis, 2018 & 2026

  • 7.2 Contraceptives Oral Solids Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Piramal Enterprises Ltd

    • 9.1.1 Piramal Enterprises Ltd Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Allergan,plc (Actavis)

    • 9.2.1 Allergan,plc (Actavis) Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Mahadev Medi World

    • 9.3.1 Mahadev Medi World Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Berar Trading Company

    • 9.4.1 Berar Trading Company Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Merck & Co., Inc.

    • 9.5.1 Merck & Co., Inc. Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Pfizer, Inc.

    • 9.6.1 Pfizer, Inc. Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Teva Pharmaceutical Industries Ltd

    • 9.7.1 Teva Pharmaceutical Industries Ltd Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 Mankind Pharma Ltd

    • 9.8.1 Mankind Pharma Ltd Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Vea Impex

    • 9.9.1 Vea Impex Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 Bayer AG

    • 9.10.1 Bayer AG Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

  • 9.11 Actiza Pharmaceutical Private Limited

    • 9.11.1 Actiza Pharmaceutical Private Limited Company overview

    • 9.11.2 Financial performance

    • 9.11.3 Product benchmarking

    • 9.11.4 Strategic initiatives

    • 9.11.5 SWOT analysis

  • 9.12 Janssen Global Services

    • 9.12.1 Janssen Global Services Company overview

    • 9.12.2 Financial performance

    • 9.12.3 Product benchmarking

    • 9.12.4 Strategic initiatives

    • 9.12.5 SWOT analysis

 

The List of Tables and Figures (Totals 73 Figures and 157 Tables)

  • Figure Progestin only pills Contraceptives Oral Solids market, 2015 - 2026 (USD Million)

  • Figure Monophasic pills Contraceptives Oral Solids market, 2015 - 2026 (USD Million)

  • Figure Triphasic pills Contraceptives Oral Solids market, 2015 - 2026 (USD Million)

  • Figure Others Contraceptives Oral Solids market, 2015 - 2026 (USD Million)

  • Figure Hospitals market, 2015 - 2026 (USD Million)

  • Figure Pharmacies market, 2015 - 2026 (USD Million)

  • Figure Drug Stores market, 2015 - 2026 (USD Million)

  • Figure Convenience Stores market, 2015 - 2026 (USD Million)

  • Figure General Stores market, 2015 - 2026 (USD Million)

  • Figure E-commerce market, 2015 - 2026 (USD Million)

  • Figure Others market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Contraceptives Oral Solids market, by country, 2015 - 2026 (USD Million)

  • Table North America Contraceptives Oral Solids market, by type, 2015 - 2026 (USD Million)

  • Table North America Contraceptives Oral Solids market, by product, 2015 - 2026 (USD Million)

  • Table North America Contraceptives Oral Solids market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Contraceptives Oral Solids market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Contraceptives Oral Solids market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Contraceptives Oral Solids market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Contraceptives Oral Solids market, by type, 2015 - 2026 (USD Million)

  • Table Canada Contraceptives Oral Solids market, by product, 2015 - 2026 (USD Million)

  • Table Canada Contraceptives Oral Solids market, by application, 2015 - 2026 (USD Million)

  • Table Europe Contraceptives Oral Solids market, by country, 2015 - 2026 (USD Million)

  • Table Europe Contraceptives Oral Solids market, by type, 2015 - 2026 (USD Million)

  • Table Europe Contraceptives Oral Solids market, by product, 2015 - 2026 (USD Million)

  • Table Europe Contraceptives Oral Solids market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Contraceptives Oral Solids market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Contraceptives Oral Solids market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Contraceptives Oral Solids market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Contraceptives Oral Solids market, by type, 2015 - 2026 (USD Million)

  • Table Germany Contraceptives Oral Solids market, by product, 2015 - 2026 (USD Million)

  • Table Germany Contraceptives Oral Solids market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Contraceptives Oral Solids market, by type, 2015 - 2026 (USD Million)

  • Table France Contraceptives Oral Solids market, by product, 2015 - 2026 (USD Million)

  • Table France Contraceptives Oral Solids market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Contraceptives Oral Solids market, by type, 2015 - 2026 (USD Million)

  • Table Italy Contraceptives Oral Solids market, by product, 2015 - 2026 (USD Million)

  • Table Italy Contraceptives Oral Solids market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Contraceptives Oral Solids market, by type, 2015 - 2026 (USD Million)

  • Table Spain Contraceptives Oral Solids market, by product, 2015 - 2026 (USD Million)

  • Table Spain Contraceptives Oral Solids market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Contraceptives Oral Solids market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Contraceptives Oral Solids market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Contraceptives Oral Solids market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Contraceptives Oral Solids market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Contraceptives Oral Solids market, by type, 2015 - 2026 (USD Million)

  • Table China Contraceptives Oral Solids market, by product, 2015 - 2026 (USD Million)

  • Table China Contraceptives Oral Solids market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Contraceptives Oral Solids market, by type, 2015 - 2026 (USD Million)

  • Table Japan Contraceptives Oral Solids market, by product, 2015 - 2026 (USD Million)

  • Table Japan Contraceptives Oral Solids market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Contraceptives Oral Solids market, by type, 2015 - 2026 (USD Million)

  • Table India Contraceptives Oral Solids market, by product, 2015 - 2026 (USD Million)

  • Table India Contraceptives Oral Solids market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Contraceptives Oral Solids market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Contraceptives Oral Solids market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Contraceptives Oral Solids market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Contraceptives Oral Solids market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Contraceptives Oral Solids market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Contraceptives Oral Solids market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Contraceptives Oral Solids market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Contraceptives Oral Solids market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Contraceptives Oral Solids market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Contraceptives Oral Solids market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Contraceptives Oral Solids market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Contraceptives Oral Solids market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Contraceptives Oral Solids market, by application, 2015 - 2026 (USD Million)

  • Table MEA Contraceptives Oral Solids market, by country, 2015 - 2026 (USD Million)

  • Table MEA Contraceptives Oral Solids market, by type, 2015 - 2026 (USD Million)

  • Table MEA Contraceptives Oral Solids market, by product, 2015 - 2026 (USD Million)

  • Table MEA Contraceptives Oral Solids market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Contraceptives Oral Solids market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Contraceptives Oral Solids market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Contraceptives Oral Solids market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Contraceptives Oral Solids market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Contraceptives Oral Solids market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Contraceptives Oral Solids market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Piramal Enterprises Ltd Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Allergan,plc (Actavis) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Mahadev Medi World Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Berar Trading Company Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Merck & Co., Inc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Pfizer, Inc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Teva Pharmaceutical Industries Ltd Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Mankind Pharma Ltd Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Vea Impex Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Bayer AG Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Actiza Pharmaceutical Private Limited Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Janssen Global Services Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$3850
$7700
BUY NOWClick MeBUY NOW
top